Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cells can be CD34+ or CD34-.

D S Donnelly1, D S Krause

  • 1Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

Leukemia & Lymphoma
|June 28, 2001
PubMed
Summary

Hematopoietic stem cells (HSCs) are not a single type. Reviewing data reveals multiple HSC populations with self-renewal and engraftment potential, challenging the traditional hierarchical model.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does salmon calcitonin cause cancer? A review and meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Illness and artistic creativity (on the 70th anniversary of the death of Béla Bartók, composer, ethnomusicologist and leukemia patient).

Leukemia·2015
Same author

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

Whole-exome sequencing identifies a novel somatic mutation in MMP8 associated with a t(1;22)-acute megakaryoblastic leukemia.

Leukemia·2013
Same author

Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia.

Leukemia·2011
Same author

Prevention of mesangial sclerosis by bone marrow transplantation.

Kidney international·2006

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Immunology

Background:

  • The traditional view of hematopoietic stem cells (HSCs) posits a fixed phenotype within a hierarchical differentiation system.
  • Changes in HSC engraftment and renewal potential were thought to occur stepwise with differentiation.

Purpose of the Study:

  • To review and synthesize data from various species and animal models regarding HSC function.
  • To challenge the existing model by presenting evidence for heterogeneity within the HSC compartment.

Main Methods:

  • Comprehensive review of published literature on hematopoietic stem cell function.
  • Analysis of data from diverse species and animal models.
  • Comparison of phenotypic markers, including CD34 expression, across different HSC populations.

Main Results:

  • The hematopoietic stem cell compartment comprises multiple phenotypically distinct populations.
  • These populations exhibit self-renewal and long-term pluripotent engraftment capabilities.
  • Some HSCs express CD34, while others do not, indicating phenotypic plasticity.

Conclusions:

  • The primitive HSC compartment is more heterogeneous than previously understood.
  • Phenotypic plasticity exists, with in vivo/ex vivo manipulations potentially altering HSC phenotypes.
  • Further research is needed to define the precise phenotypic progression and its implications for experimental transplant data interpretation.

Related Experiment Videos